Novel diagnostic platform detects SARS-CoV-2 RNA and N protein simultaneously, highlighting enhanced sensitivity and adaptability for multiplexed diagnostics.
Key Points
Simultaneous detection of SARS-CoV-2 RNA and nucleocapsid protein enhances diagnostic capabilities for viral identification.
Utilizing a dual-analyte assay, the method combines proximity ligation of aptamers and RT-qPCR for accuracy.
Approach involves high-affinity aptamers and Cy5-labeled TaqMan probes, ensuring effective target detection during analysis.
This scalable technique may improve rapid diagnostics in clinical settings, particularly for COVID-19 testing.